The incomplete penetrance and degree of conferred risk of PD in LRRK2 and GBA mutation carriers make it difficult to predict the development of disease in asymptomatic carriers and should be considered when counseling patients with PD and their families. The gene discussed is LRRK2; the disease is Parkinson disease.